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Abstract: The NMDA receptor is a major target of alcohol action in the CNS,
and recent behavioral and cellular studies have pointed to the importance of
the GluN2B subunit in alcohol action. We and others have previously
characterized four amino acid positions in the third and fourth membraneassociated (M) domains of the NMDA receptor GluN2A subunit that influence
both ion channel gating and alcohol sensitivity. In this study, we found that
substitution mutations at two of the four corresponding positions in the
GluN2B subunit, F637 and G826, influence ethanol sensitivity and ion channel
gating. Because position 826 contains a glycine residue in the native protein,
we focused our attention on GluN2B(F637). Substitution mutations at
GluN2B(F637) significantly altered ethanol IC 50 values, glutamate EC50 values
for peak (Ip) and steady-state (Iss) current, and steady-state to peak current
ratios (Iss:Ip). Changes in apparent glutamate affinity were not due to agonist
trapping in desensitized states, as glutamate Iss EC50 values were not
correlated with Iss:Ip values. Ethanol sensitivity was correlated with values of
both Ip and Iss glutamate EC50, but not with Iss:Ip. Values of ethanol IC50,
glutamate EC50, and Iss:Ip for mutants at GluN2B(F637) were highly correlated
with the corresponding values for mutants at GluN2A(F636), consistent with
similar functional roles of this position in both subunits. These results
demonstrate that GluN2B(Phe637) regulates ethanol action and ion channel
function of NMDA receptors. However, despite highly conserved M domain
sequences, ethanol's actions on GluN2A and GluN2B subunits differ.
Keywords: Alcohol, Ethanol, Glutamate, NMDA receptors

1. Introduction
Alcohol addiction, characterized by uncontrolled consumption of
alcoholic beverages despite the negative consequences, is thought to
be associated with disorganized motor function, cognition, and
aberrant learning and memory processes (Koob, 2003 and Weiss and
Porrino, 2002), all of which involve NMDA receptors. Following the
initial findings that alcohol inhibits the NMDA receptor (Hoffman et al.,
1989, Lima-Landman and Albuquerque, 1989 and Lovinger et al.,
1989), a large number of studies have established that the NMDA
receptor is a major target of alcohol action in the brain that plays a
role in several ethanol-associated phenomena such as craving,
tolerance, dependence, withdrawal, and relapse (Chandrasekar, 2013,
Gass and Olive, 2008, Holmes et al., 2013, Krishnan-Sarin et al.,
2015, Krupitsky et al., 2007, Krystal et al., 2003, Vengeliene et al.,
2005, Vengeliene et al., 2008 and Woodward, 1999). Alcohol inhibits
NMDA receptors by altering ion channel gating, specifically by
decreasing channel opening frequency and mean open time (LimaLandman and Albuquerque, 1989 and Wright et al., 1996), but does so
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via an interaction with a novel modulatory site (Chu et al., 1995,
Gonzales and Woodward, 1990, Göthert and Fink, 1989 and Peoples
and Weight, 1992). The NMDA receptor is a heterotetramer formed
from two obligatory GluN1 subunits and two GluN2 subunits, of which
four different isoforms are expressed in the brain (GluN2A-GluN2D;
(Dingledine et al., 1999)). Previous studies in our and other
laboratories have identified and characterized a number of ethanolsensitive positions in the M3 and M4 domain of the GluN1 and GluN2A
subunit (Honse et al., 2004, Ren et al., 2003a, Ren et al., 2003b, Ren
et al., 2007, Ren et al., 2012, Ren et al., 2013, Ronald et al., 2001,
Smothers and Woodward, 2006 and Xu et al., 2012). Although the
GluN2A subunit-containing NMDA receptor predominates in the
mammalian brain, the GluN2B subunit has comparable ethanol
sensitivity (Allgaier, 2002, Kuner et al., 1993, Masood et al., 1994,
Popp et al., 1998 and Smothers et al., 2001) and plays an important
role in alcohol action (Boyce-Rustay and Holmes, 2005, Izumi et al.,
2005, Kash et al., 2008, Kash et al., 2009, Nagy, 2004, Wang et al.,
2007 and Wills and Winder, 2013). However, the identity of ethanolsensitive positions in the GluN2B subunit, and whether these are
important for ion channel gating, is unknown. Because the M3 and M4
domain sequences of the GluN2A and GluN2B subunit are highly
homologous, we tested whether positions in the GluN2B M domains
corresponding to ethanol-sensitive positions in the GluN2A subunit
regulate GluN2B subunit ethanol sensitivity. Despite the high
homology between the GluN2A and GluN2B subunit M domains, we
found that mutations at only two of four cognate positions altered
alcohol sensitivity in the GluN2B subunit, and one of these is occupied
by a glycine residue in the native protein. Although ethanol may
interact with main chain carbonyl groups at positions containing
glycine residues (Dwyer, 1999), such as 826, substitution of the
glycine at this position could disrupt functional aspects of the alphahelix. Although the characteristics of the remaining position, F637,
were highly analogous to those of its cognate position in the GluN2A
subunit, the differences at the other positions suggest that there are
important differences in the action of ethanol on the GluN2A and
GluN2B subunits.
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2. Materials and methods
Chemicals. Ethanol (95%, prepared from grain) was obtained
from Pharmco-Aaper (Brookfield, CT) and all other chemicals were
obtained from Sigma–Aldrich Chemical Co. (St. Louis, MO, USA).
Chemicals used to make recording solutions were the highest purity
available.
Site-directed mutagenesis, cell culture and transfection. Sitedirected mutagenesis in plasmids containing GluN2B subunit cDNA was
performed using the QuickChange kit (Stratagene La Jolla, CA, USA),
and all mutations were verified by DNA sequencing. Transformed
human embryonic kidney (tsA 201) cells were seeded in 35-mm polyd-lysine coated dishes, and cultured in minimum essential medium
(MEM) containing 10% heat-inactivated fetal bovine serum to 70–95%
confluence. Cells were then transfected with cDNA for the GluN1-1a,
wild type or mutant GluN2B subunits and green fluorescent protein
(pGreen Lantern; Invitrogen, Carlsbad, CA) at a 2:2:1 ratio using
calcium phosphate transfection kit (Invitrogen). After transfection,
200 μM dl-2-amino-5-phosphonovaleric acid (APV) and 100 μM
ketamine were added into culture medium to protect cells from
receptor-mediated excitotoxicity. Cells were recorded within 48 h
following transfection. Antagonists were removed before recording by
extensive washing.
Electrophysiological recording. Whole-cell patch-clamp
recordings were performed at room temperature using an Axopatch 1D
or 200B amplifier (Molecular Devices, Sunnyvale, CA, USA). Gigaohm
seals were formed in whole-cell recording using patch pipettes with tip
resistances of 2–4 MΩ, and series resistances of 1–5 MΩ were
compensated by 80%. Cells were voltage-clamped at −50 mV and
superfused in an external recording solution containing (in mM): NaCl,
150; KCl, 5; CaCl2, 0.2; HEPES, 10; glucose, 10; and sucrose, 10;
osmolality was adjusted to 340 mmol/kg with sucrose. The ratio of
added HEPES free acid and sodium salt was calculated to result in a
solution pH of 7.4 (Buffer Calculator, R. Beynon, University of
Liverpool); final pH was adjusted, if necessary, using HCl or NaOH.
Low Ca2+ was used to minimize NMDA receptor inactivation, and EDTA,
10 μM, was added to the recording solution to eliminate the fast
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component of apparent desensitization due to high-affinity Zn2+
inhibition ( Low et al., 2000, Ren et al., 2003b and Erreger and
Traynelis, 2005). Recording solutions were prepared fresh daily and
applied to cells using a stepper motor-driven solution exchange
apparatus (Warner Instruments, Hamden, CT, USA) and three-barrel
square glass tubing of internal diameter 600 μm. The intracellular
recording solution (patch-pipette) contained (in mM) CsCl, 140;
Mg4ATP, 2; BAPTA, 10; and HEPES, 10 (pH 7.2). In order to increase
the speed of the solution exchange in glutamate concentrationresponse experiments, cells were lifted off the surface of the dish after
gaining a gigaohm seal. Data were filtered at 2 kHz (8-pole Bessel)
and acquired at 5 kHz on a computer using a DigiData interface and
pClamp software (Molecular Devices).
Calculation of physicochemical properties of amino acids.
Molecular (Van der Waals) volumes of amino acids were calculated
using Spartan Pro (Wavefunction, Inc., Irvine, CA) following structural
optimization using the AM1 semi-empirical parameters. Values used
for amino acid hydropathy, hydrophilicity, and polarity were reported
previously ( Ren et al., 2003b).
Molecular modeling. Molecular modeling was performed on a
Dell T3500 workstation with Discovery Studio 3.1 software (Accelrys,
now Biovia; San Diego, CA). A model of a truncated version of the
NMDA receptor was built based on the crystal structure of the rat
NMDA heterotetramer that included both the ligand-binding and
channel domains ( Karakas and Furukawa, 2014). We constructed a
model confined to the channel structure of the protein and excluded
the ligand-binding domain. The 4PE5 PDB file was used as a source of
atomic coordinates and the sequences of rat GluNR1 and GluNR2B or
GluNR2A subunits were aligned to the 4PE5 sequence. The original
crystal structure lacks a number of key loops or segments, so these
were built in piecemeal fashion using insert loop commands and, in
some cases, by grafting a desired loop or segment to a new location. A
model with the GluNR2B subunit was constructed first, and the version
of the tetramer with the GluNR2A subunit was created from this model
by mutating individual amino acids that differ in the two sequences.
The structures were subjected to the same limited energy minimization
regimen to resolve any major steric bumps.
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Data analysis. In concentration-response experiments, IC50 or
EC50 and n (slope factor) were calculated using the equation:
y = Emax/1 + (IC50 or EC50/x)n, where y is the percent inhibition (for
IC50) or the measured current amplitude (for EC50), x is concentration,
and Emax is the maximal current amplitude. Statistical differences
among concentration-response curves were determined by comparing
log-transformed IC50 or EC50 values from fits to data obtained from
individual cells using one-way analysis of variance (ANOVA) followed
by the Dunnett test. Linear relations of mean values of log IC50, log
EC50, or maximal steady-state to peak current ratio (ISS:IP) for the
various mutants in GluN2A and GluN2B subunit were made using
linear regression analysis. Values of log IC50, log EC50, and maximal
steady-state to peak current ratio (ISS:IP) for GluN2A mutants are from
previous studies ( Ren et al., 2003a, Ren et al., 2007, Ren et al.,
2013 and Honse et al., 2004). Time constants (τ) of deactivation were
determined from fits of the current decay following the removal of
glutamate (in the continued presence of glycine) to an exponential
function using Clampfit (Axon Instruments). In most cells, deactivation
was best fitted using a bi-exponential function; in these cases, the
weighted time constant is reported. For cells in which deactivation was
adequately fitted by a single exponential function, this value is
reported. All values are reported as the mean ± SE.

3. Results
3.1. Effects of mutations at positions in GluN2B subunit
M domains corresponding to alcohol-sensitive positions
in GluN2A subunits
The M3 and M4 domains are highly conserved among GluN1,
GluN2A and GluN2B subunits (Fig. 1A). Previous studies from this
laboratory have identified and characterized a number of ethanolsensitive positions in these domains of the GluN2A subunit (Fig. 1B)
(Honse et al., 2004, Ren et al., 2003b, Ren et al., 2007 and Ren et al.,
2013). In this study, we initially constructed tryptophan and alanine
substitutions at positions that correspond to ethanol-sensitive residues
in the GluN2A subunit: Phe637, Phe638, Met824, and Gly826.
Concentration-response experiments for ethanol inhibition showed that
tryptophan or alanine mutations at Phe637 significantly changed
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ethanol IC50 compared with the wild-type receptor, but that neither
substitution altered ethanol sensitivity at F638 or M824. Tryptophan
mutagenesis at GluN2B(Gly826) exhibited significantly decreased
ethanol sensitivity compared with the wild-type receptor (Fig. 2A–B;
ANOVA and Dunnett's test; p < 0.01 or p < 0.05). The effects of these
substitutions in GluN2B on alcohol sensitivity thus substantially differ
from the corresponding mutations in the GluN2A subunit ( Fig. 2C–D).
Because the native residue at position 826 is glycine, and thus lacks a
side chain, we chose to focus our investigation on GluN2B(F637). In
order to study the role of GluN2B(Phe637) on ethanol action in detail,
we made a panel of mutants at this position and tested ethanol
sensitivities using whole-cell patch-clamp recording. All mutants we
constructed yielded functional receptors that were inhibited by ethanol
in a concentration-dependent manner (Fig. 3). Concentration-response
curves for ethanol inhibition were essentially parallel to each other, as
their slope factors did not differ significantly.

Fig. 1. Positions in the GluN2B subunit M3 and M4 domains corresponding to alcoholsensitive positions in the GluN2A subunit. A. Partial sequences of the M3 and M4
domains in GluN2A and GluN2B subunits. Ethanol-sensitive positions in GluN2A and
their cognate positions in GluN2B are indicated in bold. GluN2B(Phe637) is underlined.
B. Topological model of the GluN2B subunit showing the amino-terminal domain
(ATD), ligand binding domain (LBD) composed of lobes S1–S2, and membraneassociated domains (M1-M4) with the residues corresponding to the alcohol-sensitive
positions in GluN2A shown as spheres.
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Fig. 2. Ethanol sensitivity of tryptophan and alanine substitution mutations at GluN2B
M3 and M4 residues corresponding to GluN2A ethanol-sensitive positions. A.
Concentration-response curves show ethanol inhibition of glutamate–activated
currents in the presence of 50 μM glycine in cells expressing either wild-type GluN1
and GluN2B subunits or wild-type GluN1 and GluN2B tryptophan mutants at Phe637,
Phe638, Met824, or Gly826. One-letter amino acid codes are used. Error bars are not
shown to increase clarity. Curves shown are the best fits to the equation given under
“ Materials and methods”. The curve for the wild-type receptor is shown as a dashed
line. B. Bar graphs show average IC50 values for ethanol inhibition of glutamateactivated current in the presence of 50 μM glycine in cells expressing wild-type GluN2B
or GluN2B mutant subunits. IC50 values that are significantly different from the wildtype receptor are indicated by asterisks (*P < 0.05; **P < 0.01; ANOVA and
Dunnett's test). Results are means ± S.E of 5–7 cells. C. The M3 and M4 domains
showing the approximate locations of the five positions tested. D. Comparison of
ethanol IC50 values of various alanine or tryptophan mutants to the wild-type value.
The x-axis shows the ethanol IC50 values of GluN2A subunit alanine (black circles) and
tryptophan (black squares) substitutions and GluN2B subunit alanine (gray circles) and
tryptophan (gray squares) substitutions at these positions. Ethanol IC50 values of wildtype GluN2A-containing NMDA receptors (black dotted line) and GluN2B-containing
NMDA receptors (gray dotted line) are shown. Ethanol IC50 values for alanine and
tryptophan substitutions at various positions in GluN2A subunit are from ( Honse
et al., 2004, Ren et al., 2003b, Ren et al., 2007 and Ren et al., 2013).
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Fig. 3. Mutations at GluN2B(Phe637) alter ethanol sensitivity. A. Traces show currents
activated by 10 μM glutamate in the presence of 50 μM glycine and their inhibition by
100 mM ethanol in cells expressing the GluN1 subunit with either wild-type GluN2B
subunits or various GluN2B(Phe637) mutant subunits. One-letter amino acid codes are
used. B. Concentration-response curves for ethanol inhibition of glutamate-activated
currents in the presence of 50 μM glycine in cells expressing various substitution
mutations at GluN2B(Phe637). Results are the means ± S.E of 5–7 cells. Error bars
are not shown to increase clarity. The dashed line shows the fit for the wild-type
receptor. All curves are best fits to the equation given under “ Materials and methods”.
C. Average IC50 values for ethanol inhibition of glutamate-activated current in wildtype or GluN2B(Phe637) mutant receptors. Asterisks indicate significant differences
from the IC50 value of the wild-type receptor (*P < 0.05; **P < 0.01; ANOVA and
Dunnett's test). Results are the means ± S.E of 5–7 cells.

Six out of ten substitution mutants at GluN2B(Phe637) showed
significantly decreased ethanol sensitivity compared to the wild-type
(WT) receptor (ANOVA; p < 0.05 or p < 0.01), however, none of the
mutants exhibited increased ethanol sensitivity. Interestingly, although
isoleucine and leucine are isomeric amino acids, ethanol sensitivity
was significantly changed by substitution of isoleucine (IC50 value:
307 ± 9.41 mM; ANOVA and Dunnett's test; p < 0.01), but not leucine
(IC50 value: 150 ± 1.32 mM; ANOVA and Dunnett's test; p > 0.05).

3.2. Mutations at GluN2B(Phe637) of NMDA receptor
alter NMDA receptor function
Previous studies showed that ethanol inhibits NMDA receptors
by altering ion channel gating, primarily by decreasing mean open
time of the channel, and studies from our laboratory reported that
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mutations at ethanol-sensitive positions in the GluN2A subunit also
strongly influence ion channel gating kinetics (Ren et al., 2003a, Ren
et al., 2007, Ren et al., 2008, Ren et al., 2013 and Honse et al.,
2004). In this study, we first compared glutamate peak and steadystate EC50 values between GluN2B wild-type and GluN2B(F637W)
mutant subunits. The GluN2B(F637W) mutant showed significantly
decreased glutamate EC50 values for peak (1.1 ± 0.17 μM; ANOVA and
Dunnett's test; p < 0.01) and steady-state current (1.05 ± 0.16 μM;
ANOVA and Dunnett's test; p < 0.01; Fig. 4A and B). In addition, the
mutant receptor also showed significantly decreased apparent
desensitization, as indicated by the Iss:Ip ratio for 300 μM glutamateactivated current (Fig. 4C; ANOVA and Dunnett's test; p < 0.01), and
an increased time constant of deactivation (τ) following removal of
agonist (F637W: 2170 ± 2.84 ms; WT: 920 ± 3.30 ms; ANOVA;
p < 0.0001; Fig. 4D). To further determine whether mutations at
GluN2B(Phe637) can influence NMDA receptor characteristics, we
performed glutamate concentration-response experiments on all
mutants tested for ethanol sensitivity (Fig. 5). Seven out of ten
mutants showed significantly decreased glutamate Ip EC50 values
(ANOVA and Dunnett's test; p < 0.01; Fig. 6A), but only five mutants
showed decreased glutamate Iss EC50 values (ANOVA and Dunnett's
test; p < 0.01; Fig. 6B). Interestingly, there was again a difference
between the isoleucine and leucine mutants, in that isoleucine
substitution significantly altered glutamate Iss EC50 (0.85 ± 0.078 μM;
ANOVA and Dunnett's test; p < 0.01), whereas leucine substitution did
not (2.5 ± 0.24 μM; ANOVA and Dunnett's test; p > 0.05; Fig. 6B).
Pronounced increases were observed for maximal Iss:Ip ratios in all
mutants (ANOVA and Dunnett's test; p < 0.01; Fig. 6C).
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Fig. 4. Tryptophan substitution at GluN2B(Phe637) alters glutamate potency,
desensitization, and deactivation. A. Glutamate concentration-response curves for
glutamate-activated peak and steady-state currents in the presence of 50 μM glycine
in lifted cells expressing GluN1/GluN2B or GluN1/GluN2B(F637W) receptors. Data
points are the means ± S.E of 6 cells. Error bars are not shown to increase clarity.
Curves shown are best fits to the equation in “ Materials and methods” for peak
(black) and steady-state (gray) currents. B. Average peak (open bars) and steadystate (cross-hatched bars) current EC50 values recorded in lifted cells expressing either
wild-type GluN1/GluN2B receptors or GluN1/GluN2B(F637W) receptors. Values that
differed significantly from wild-type peak and steady-state current EC50 values are
indicated by asterisks (**P < 0.01; ANOVA and Dunnett's test). Results are the
means ± S.E of 6 cells. C. Normalized traces show the desensitization of 300 μM
glutamate-activated current in the presence of 50 μM glycine in lifted cells expressing
either wild-type GluN1/GluN2B or GluN1/GluN2B(F637W) receptors. D. Normalized
traces show the difference in the deactivation of glutamate-activated current following
removal of glutamate in lifted cells expressing either wild-type GluN1/GluN2B or
GluN1/GluN2B(F637W) subunits.
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Fig. 5. Mutations at GluN2B(Phe637) alter glutamate EC50.A. Traces show 300 μM
glutamate-activated current in the presence of 50 μM glycine in lifted cells expressing
wild-type receptors or receptors containing various substitutions at GluN2B(Phe637).
One-letter amino acid codes are used. B–C. Concentration-response curves for
glutamate-activated peak (B) and steady-state (C) current recorded from lifted cells
expressing wild-type or mutant receptors. Results are the means ± S.E of 4–6 cells.
Error bars are not shown to increase clarity. All curves shown are best fits to the
equation described in “ Materials and methods”. The dashed curves indicate the fits for
the wild-type receptor.

Fig. 6. Mutations at GluN2B(Phe637) change glutamate potency. Bar graphs show the
average EC50 values for glutamate-activated peak (A) and steady-state (B) currents
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recorded from cells expressing GluN1 and wild-type GluN2B or GluN2B(Phe637)
mutant subunits. Asterisks indicate EC50 values that differ significantly from that of the
wild-type GluN1/GluN2B subunit (**P < 0.01; ANOVA and Dunnett's test). Results are
the means ± S.E of 4–6 cells. C. The average values of maximal steady-state to peak
current ratio (Iss:Ip) in lifted cells co-expressing GluN1 and GluN2B wild-type subunits
or GluN2B subunits containing various substitutions at F637. Currents were activated
by 300 μM glutamate in the presence of 50 μM glycine. Asterisks indicate Iss:Ip values
that are significantly different from the value for the wild-type GluN1/GluN2B subunit
(**P < 0.01; ANOVA and Dunnett's test). Results are the means ± S.E of 4–6 cells.

Figure options

3.3. Relation of GluN2B(Phe637) mutant peak current
glutamate EC50, steady-state EC50, and maximal
steady-state to peak current ratio
For a series of mutants at GluN2A(F636), glutamate EC50 values
for steady-state current were highly correlated with those for peak
current, but not with values of Iss:Ip (Ren et al., 2013). In the present
study, we observed that peak current glutamate EC50 values were
strongly correlated with steady-state current glutamate EC50 values
(R2 = 0.95, P < 0.0001; Fig. 7A). However, EC50 values for glutamateactivated steady-state current for mutants at GluN2B(F637) were not
significantly correlated with maximal Iss:Ip values (R2 = 0.014,
P > 0.05; Fig. 7B).

Fig. 7. Correlations among glutamate peak and steady-state current EC50 ethanol IC50
values. A. Graph plots values of glutamate log EC50 for steady-state current versus
peak current in a series of mutants. Glutamate EC50 values for peak and steady-state
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current were significantly correlated (R2 = 0.95, P < 0.0001). The lines shown are the
least squares fits to the data. B. Graph plots log maximal steady-state to peak current
ratio (Iss:Ip) versus either glutamate peak current log EC50 values or glutamate steadystate current log EC50 values for various GluN1/GluN2B(Phe637) mutant receptors. Log
maximal Iss:Ip for glutamate was not correlated with either peak or steady-state
glutamate EC50 (p > 0.05). The lines shown are the least squares fits to the data. C–D.
Graphs plot log ethanol IC50 values in a series of mutants versus log values of
glutamate EC50 for peak or steady-state current (C) or the maximal Iss:Ip values (D).
Ethanol IC50 values were correlated with glutamate EC50 for peak (R2 = 0.75,
p < 0.001) and steady-state current (R2 = 0.59, p < 0.005), but not with Iss:Ip values
(R2 = 0.19, p > 0.05). The lines shown are the least squares fits to the data.

3.4. Determinants of ethanol sensitivity and receptor
function among mutants at GluN2B(Phe637)
To determine the manner in which the physical–chemical
properties of the substituent at GluN2B(F637) contribute to the
changes in ethanol IC50 values, glutamate EC50 values, and Iss:Ip
values, we tested for linear relations of these values to amino acid
polarity, hydrophilicity, and molecular volume. However, no significant
linear relations were detected among these measures (Table 1).
Table 1. Relation of NMDA receptor agonist potency and ethanol sensitivity to the
physicochemical parameters of the substituent at GluN2B(Phe637).
Glutamate Ip EC50
R2

P value

Ethanol IC50
R2

P value

Molecular volume

0.107

>0.05

0.073

>0.05

Hydrophilicity

0.081

>0.05

0.109

>0.05

Polarity

0.022

>0.05

0.034

>0.05

Because substitution mutations at GluN2B(Phe637) altered both
ethanol sensitivity and NMDA receptor function, we asked whether the
observed changes in ethanol sensitivity among the series of mutant
subunits might have resulted from changes in agonist potency or ion
channel gating kinetics. Plots of ethanol IC50 values against values of
glutamate EC50 for peak current, steady-state current, or maximal
Iss:Ip revealed that ethanol sensitivity of mutants was significantly
negatively correlated with both peak (R2 = 0.75, p < 0.001; Fig. 7C)
and steady-state (R2 = 0.59, p < 0.005) current EC50 values, but was
not correlated with maximal Iss:Ip (p > 0.05; Fig. 7D).
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3.5. Effects of mutations at GluN2B(Phe637) and
GluN2A(Phe636) on ethanol sensitivity and ion channel
function are similar
Because mutations at GluN2B(Phe637) and at its cognate
position, GluN2A(Phe636), can both alter ethanol sensitivity and ion
channel function (Ren et al., 2013), we evaluated whether the side
chain at this position regulates the ion channel in a similar manner in
the two subunits. We thus tested for correlations among mutants at
GluN2B(Phe637) and GluN2A(F636) for glutamate Ip and Iss EC50,
maximal Iss:Ip, and ethanol IC50 values. For the two series of mutants
at GluN2B(F637) and GluN2A(F636), we observed significant
correlations for values of glutamate EC50 for peak (R2 = 0.84,
p < 0.0001; Fig. 8A) and steady-state (R2 = 0.76, p < 0.001; Fig. 8B)
current, maximal Iss:Ip (R2 = 0.49, p < 0.05; Fig. 8C), and ethanol IC50
(R2 = 0.95, p < 0.0001; Fig. 8D).

Fig. 8. Ethanol sensitivity and glutamate EC50 values of GluN2B(Phe637) mutants are
correlated with these parameters in GluN2A(Phe636) mutants. A–B. Graphs plot log
values of either Ip EC50 (A) or Iss EC50 (B) for GluN2B(Phe637) mutants versus each of
these two parameters for GluN2A(Phe636) mutants. Both peak and steady-state
glutamate EC50 values were significantly correlated in the two subunit types
(R2 = 0.84, P < 0.0001 and R2 = 0.76, P < 0.001, respectively). The lines shown are
the least squares fits to the data. C. Values of maximal steady-state to peak current
ratio (Iss:Ip) of GluN2B(Phe637) and GluN2A(Phe636) mutant receptors were
significantly correlated (R2 = 0.49, P < 0.05). The line shown is the least squares fits
to the data. D, Log ethanol IC50 values for mutants at GluN2B(Phe637) and
GluN2A(Phe636) were significantly correlated (R2 = 0.95, P < 0.0001). The line shown
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is the least squares fit to the data. Ethanol IC50 values, glutamate EC50 values, and
maximal Iss:Ip values of GluN2A(Phe636) mutants are from a previous study in this
laboratory (Ren et al., 2013).

4. Discussion
We and others have used alanine- and tryptophan-scanning to
identify alcohol-sensitive positions in the GluN1 and GluN2A subunits
(Ren et al., 2003b, Ren et al., 2007, Ren et al., 2012, Ronald et al.,
2001, Salous et al., 2009 and Smothers and Woodward, 2006).
Previous studies in this laboratory identified several ethanol-sensitive
positions in both the M3 and M4 domains of the GluN2A subunit:
Phe636, Phe637, Met823, and Ala825 (Honse et al., 2004, Ren et al.,
2003b, Ren et al., 2007 and Ren et al., 2013). In the present study,
alanine and tryptophan substitutions were initially introduced into the
cognate positions in the GluN2B subunit M3 and M4 domains, which
are Phe637, Phe638, Met824, and Gly826. The results of the present
study show, however, that the role of these positions in the GluN2A
and GluN2B subunits in determining ethanol sensitivity differs. For
example, tryptophan mutagenesis at GluN2A(Phe637) increases
ethanol IC50 by over two-fold relative to the wild-type value (Ren
et al., 2007), whereas in the GluN2B subunit, tryptophan substitution
at the cognate position, Phe638, had no effect on ethanol sensitivity.
Of the four positions in the GluN2B subunit we tested in this study,
only Phe637 showed alterations in ethanol sensitivity following both
tryptophan and alanine mutagenesis. We also found no changes in
glutamate EC50, maximal Iss:Ip, or deactivation time constant in alanine
or tryptophan substitution mutants at Phe638 or Gly826 (results not
shown). Interestingly, alanine or tryptophan substitution at Met824
altered glutamate steady-state EC50 and maximal Iss:Ip values (results
not shown), as was observed for the cognate position Met823 in
GluN2A ( Ren et al., 2003a), but did not alter ethanol sensitivity. It
should be noted, however, that the effect of mutations at
GluN2A(M823) on ethanol sensitivity is significant, but relatively small,
so that a subtle difference at this position in the GluN2B could account
for its lack of regulation of ethanol sensitivity. The tryptophan mutant
at Phe637 showed increases in both glutamate EC50 and time constant
of deactivation, and both tryptophan and alanine mutants at this
position showed decreased macroscopic desensitization.
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Although the GluN2A and GluN2B subunit share highly
conserved M domain sequences, our observations demonstrate that
ethanol's actions on the two subunits differ considerably. Our
laboratory has reported that two positions in the GluN2A M3 and M4
domains can functionally interact to regulate ethanol sensitivity (Ren
et al., 2008), and Smothers and Woodward (2006) identified a pair of
positions in the GluN1 subunit that can functionally interact with
respect to ethanol inhibition. Positions at the intersubunit M3-M4
domain interfaces interact to regulate ethanol sensitivity and ion
channel function (Ren et al., 2012), and can also form three-way
interactions with M1 domain residues (Xu et al., 2015). Thus, multiple
ethanol-sensitive positions appear to form sites of ethanol action.
Therefore, the differences in ethanol action between GluN2A and
GluN2B subunits identified in this study may arise because positions in
the GluN2B subunit interact with other positions in GluN2B or GluN1 in
a manner that differs from the cognate positions in the GluN2A
subunit. One possible candidate for such an interacting position is an
isoleucine at position 571 in the M1-M2 linker of the GluN2A subunit,
which corresponds to a valine at 572 in the GluN2B subunit (Fig. 9).
Our energy-minimized models of this region place GluN2A(I571)
sufficiently close to a substituted tryptophan at 637 to result in a steric
interaction between these side chains, which may explain the ability of
the substituted tryptophan to decrease the sensitivity of the receptor
to ethanol. In contrast, the considerable distance between
GluN2B(Val572) and position 638 could easily accommodate a
substituted tryptophan at 638 without steric interaction, so that
mutations at 638 would not alter ethanol action. An alternative
possibility is that differences among subunits may arise due to
regulation of ethanol sensitivity by distant parts of the protein. Many
studies from this and other laboratories have established that positions
in the M domains are critically important for the action of ethanol
(Honse et al., 2004, Ren et al., 2003a, Ren et al., 2003b, Ren et al.,
2007, Ren et al., 2012, Ren et al., 2013, Ronald et al., 2001,
Smothers and Woodward, 2006, Smothers et al., 2013 and Xu et al.,
2012). For example, a recent study from this laboratory found that
mutating only two of ten ethanol-sensitive positions in M3 and M4
could increase the NMDA receptor ethanol IC50 value to over 1 M,
rendering it insensitive to physiological concentrations of ethanol (Ren
et al., 2012). However, although the NMDA receptor C-terminal and N-
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terminal domains are not required for the action of ethanol (Peoples
and Stewart, 2000 and Smothers et al., 2013), both regions can
influence ethanol sensitivity (Alvestad et al., 2003, Anders et al.,
1999, Anders et al., 2000, Peoples and Stewart, 2000 and Smothers
et al., 2013), leaving open the possibility that these or other regions
could contribute to the differences in alcohol action observed in
GluN2A and GluN2B M domain mutants.

Fig. 9. Tryptophan substitution at a position in M3 differs in the GluN2A and GluN2B
subunits. Molecular models of the NMDA receptor M domains showing tryptophan
substitution at 637 in GluN2A (A) or 638 in GluN2B (B). Note the difference in the
potentially interacting isoleucine 571 in GluN2A vs. valine 572 in GluN2B. The ribbon
for GluN1 is colored green and for GluN2A/2B is colored red. The proteins are
superimposed so that the perspective is the same for both. The models were subjected
to equal amounts of energy minimization.

Previous studies have found a relation between molecular
volume of the side chain at sites of alcohol action in GABAA and glycine
receptors (Kash et al., 2003, Mihic et al., 1997, Wick et al.,
1998 and Yamakura et al., 1999), in the M4 domain of the GluN2A
subunit (Ren et al., 2003b), and at the cognate position to
GluN2B(Phe637) in the M3 domain of the NMDA receptor GluN1
subunit (Smothers and Woodward, 2006) and GluN2A subunit (Ren
et al., 2007). Although substitution mutations at GluN2B(Phe637)
could significantly alter ethanol sensitivity, ethanol IC50 was not related
to side chain molecular volume among the GluN2B(Phe637) mutants
tested. One explanation for this may be that the side chain at 637 may
not directly project into the interior of the ethanol-sensitive site, but
may rather form part of the outer boundary of this site. The reason for
the discrepancy between the role of molecular volume at this position
in the GluN2A and GluN2B subunits, however, is not clear at present,
but serves as additional evidence that the sites of alcohol action on the
two subunit types differ. The results of the present study also did not
show any relation between ethanol sensitivity and the hydrophilicity of
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the substituent at GluN2B(Phe637). Although such a relation was
observed among mutants at GluN2A(Met823), indicating a possible
role for hydrophobic binding (Ren et al., 2003b), similar relations were
not observed for other positions (Ren et al., 2007 and Salous et al.,
2009). The lack of a clear role for molecular volume and
hydrophobicity in the present study was particularly apparent when
comparing the leucine and isoleucine mutants: there was a striking
difference in ethanol sensitivity between the two mutants, even though
they have identical physicochemical characteristics. Thus,
GluN2B(Phe637) can regulate receptor ethanol sensitivity in a complex
manner that relies on the interaction between side chains at this
position and other positions. Further studies will be needed to define
these interactions.
All GluN2B(Phe637) mutants tested in this study showed
decreased peak glutamate EC50 values and increased maximal Iss:Ip
values, and only three showed decreased steady-state glutamate EC50
values. Because Phe637 is in the M3 domain, which has an important
role in NMDA receptor ion channel gating, and is at a considerable
distance from the ligand binding domain (Low et al., 2003, Sobolevsky
et al., 2007, Sobolevsky et al., 2009 and Yuan et al., 2005), the
changes in glutamate EC50 values among mutants at this position
appear to result from modifications in ion channel gating. Although we
did not determine direct measures of ion channel gating, such as mean
open time, in this study, the differences in macroscopic desensitization
indicate alterations in ion channel gating among the mutants. The
observed differences in current amplitude among mutants at
GluN2B(F637) may also result from altered ion channel gating. The
isoleucine and leucine mutants also differed from each other with
respect to glutamate EC50, such that isoleucine, but not leucine,
substitution increased peak and steady-state glutamate EC50. This
indicates that not only ethanol sensitivity of the NMDA receptor, but
also ion channel gating, is sensitive to subtle structural alterations in
the side chain at 637. A previous study showed that tryptophan
substitution at GluN2A(Met823) significantly altered both glutamate Iss
EC50 and desensitization (Ren et al., 2003a), and that the changes in
glutamate steady-state EC50 values among mutants at this position
were due to agonist trapping in desensitized states. For a series of
amino acid substitutions at Phe636 in the GluN2A subunit, which is the
cognate position of GluN2B(Phe637), Iss:Ip values had an inverse
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relationship with peak glutamate EC50 values, but were not correlated
with glutamate steady-state EC50 values (Ren et al., 2013). In
GluN2B(Phe637) mutants, however, glutamate peak and steady-state
EC50 values were highly correlated, but neither were correlated with
maximal Iss:Ip values, indicating that agonist potency can be influenced
by the substituent at this position in a manner that is independent of
changes in desensitization. The mechanism for this appears to be due
to changes in ion channel gating, such as increases in mean open
time, that secondarily affect agonist binding. Thus, although
GluN2A(Phe636) and GluN2B(Phe637) are cognate positions, and
mutations at both positions affect ethanol sensitivity in a remarkably
similar manner, their roles in regulation of ion channel function differ.
Previous studies in our laboratory showed that ethanol
sensitivity of the NMDA receptor was inversely correlated with
glutamate EC50. In these studies, we observed that mutations at
GluN2A(F636) and GluN2A(F637) that had higher agonist potency
exhibited lower ethanol sensitivity (Ren et al., 2007 and Ren et al.,
2013). Similar inverse correlations between ethanol sensitivity and
glutamate peak, steady-state EC50, or apparent desensitization were
observed in the current study at GluN2B(Phe637). Ethanol can
influence desensitization in a number of ion channels (Dopico and
Lovinger, 2009 and Moykkynen et al., 2003). It is possible that
changes in ethanol sensitivity observed in the present study are
secondary to alterations of ion channel function in GluN2B subunitcontaining NMDA receptors, but this possibility is not consistent with
results of previous studies in which ethanol inhibition of NMDA
receptors did not involve changes in desensitization (Peoples et al.,
1997, Ren et al., 2003b and Woodward, 2000). Furthermore, studies
in cells expressing GluN1/GluN2A(F636W) NMDA receptors showed
that ethanol sensitivity was not altered when ethanol was either preapplied for 10 s before receptor was activated or when ethanol was
applied during steady-state current (Ren et al., 2013). In the present
study, we found that steady-state and peak current inhibition in
mutants at GluN2B(Phe637) do not differ (results not shown). It thus
appears most likely that similar factors may influence both ion channel
kinetics and ethanol sensitivity in parallel.
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5. Conclusions
Although the GluN2A and GluN2B subunit M3 and M4 domains
are highly homologous, substitution mutations at only two of four
positions tested affect alcohol sensitivity in both subunits.
Furthermore, as GluN2B(826) is occupied by a glycine in the native
protein, the side chain at this position is unlikely to participate in
alcohol inhibition, although the main chain carbonyl group may do so
(Dwyer, 1999). The characteristics of the remaining position,
GluN2B(637), were highly analogous to those of its cognate position in
the GluN2A subunit, suggesting that there are both important
similarities and differences in the action of ethanol on the GluN2A and
GluN2B subunits.
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